AMC Entertainment (NYSE: AMC) reported its Q1 2026 financials, with total revenue rising to $1.05 billion, from $862.5 million a year earlier.
Breaking it down, admissions revenue climbed to $578.4 million from $473.5 million, food and beverage revenue rose to $347.3 million from $283.4 million, and other theatre revenue increased to $119.7 million from $105.6 million.
Operating loss narrowed to $45.7 million from $145.9 million as higher revenue outpaced the increase in operating costs.
Net loss then also improved to $117.1 million from $202.1 million, while diluted loss per share improved to $0.22 from $0.47. On adjusted basis, net loss improved to $194.3 million from $250.0 million. Adjusted diluted loss per share improved to $0.36 from $0.58.
Adjusted EBITDA was $38.3 million, compared with negative $57.7 million a year earlier, a $96.0 million improvement and AMC’s best first-quarter adjusted EBITDA since 2019.
Net cash used in operating activities was $128.5 million, compared with $370.0 million a year earlier. Free cash flow was negative $174.7 million, compared with negative $417.0 million, while capital expenditures were nearly flat at $46.2 million versus $47.0 million.
AMC ended the quarter with $339.2 million in cash and cash equivalents, excluding $41.7 million of restricted cash, down from $428.5 million at year-end 2025.
The company raised approximately $71.7 million in gross proceeds through an at-the-market sale of about 62.1 million Class A shares. AMC also exercised Hycroft Mining warrants at $10.68, received 765,440 Hycroft shares, and sold 700,000 shares at an average price of $42.40 for $29.7 million before commissions. Including prior Hycroft sales, AMC has realized $53.8 million in proceeds against its original $27.9 million investment and still held 129,478 Hycroft shares as of March 31.
AMC last traded at $1.59 on the NYSE, up 9.66%.
Information for this story was found via the sources and the companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
